Thank you, the Cell example is helpful. If you look up Cell on Sherpa Romeo you will see that authors can self-archive their preprint on noncommercial servers such as arXiv and bioRxiv at no cost and with no delay: https://www.sherpa.ac.uk/romeo/search.php?source=journal&sourceid=6580&la=en&fIDnum=|&mode=simple
In brief: this is what I recommend to authors and funders. Details: Relyx (Elsevier's parent company) is a corporation with a mandate to return profit to shareholders. In the case of Cell, revenue and profit is derived from selling the journal through subscriptions and selling re-use rights. For-profit scholarly publishers by definition must make a profit. 181 USD for the use of 5 figures is a model of transparency and a bargain in comparison with legally obligatory non-transparent blanket licensing as Canada's copyright collectives are demanding for limited rights that might not cover this case. If the figures are in an arXiv version and the downstream author cannot afford the 181 USD, they can cite the arXiv version at no cost. There is a small cost in inconvenience, but no loss of knowledge. Elsevier appears to be interpreting NC as necessary to their downstream commercial re-use rights. This is a matter of interpretation. NC/ND with author copyright means authors retain these rights, not publishers. CC licenses with no NC grant blanket commercial rights to anyone. Under CC-BY for example, anyone could charge whatever they like for the 5 figures. Whether they could do this through CCC per se depends on CCC policy and practice, not the license. With blanket downstream commercial rights, anyone can set up a for-pay image database. My recommendation: authors of Cell articles should self-archive preprints for open access and take advantage of pre-submission peer review (a community practice in arXiv) in order to post a preprint that has been peer reviewed. For the future: further develop this model and eliminate the role of the for-profit publisher. I do not recommend paying for Elsevier postprint OA under any license. Their use of NC and ND is problematic. but so is their use of CC-BY. best, Dr. Heather Morrison Associate Professor, School of Information Studies, University of Ottawa Professeur Agrégé, École des Sciences de l'Information, Université d'Ottawa Principal Investigator, Sustaining the Knowledge Commons, a SSHRC Insight Project sustainingknowledgecommons.org [email protected] https://uniweb.uottawa.ca/?lang=en#/members/706 [On research sabbatical July 1, 2019 - June 30, 2020] ________________________________ From: [email protected] <[email protected]> on behalf of Peter Murray-Rust <[email protected]> Sent: Thursday, September 12, 2019 5:02:15 PM To: Global Open Access List (Successor of AmSci) <[email protected]> Subject: Re: [GOAL] Call for applications - International Open Access Advisory Group Attention : courriel externe | external email Typical example, Skimmed through Cell to the first CC - NC - ND article: DOI: https://doi.org/10.1016/j.cell.2019.05.055 Copyright © 2019 The Author(s). Published by Elsevier Inc. User License Creative Commons Attribution – NonCommercial – NoDerivs (CC BY-NC-ND 4.0)<http://creativecommons.org/licenses/by-nc-nd/4.0/> | How you can reuse<https://www.cell.com/cell/fulltext/S0092-8674(19)30626-9#> [Information Icon] Go to RightsLInk Enter as academic author writing a book with CUP and requiring 5 figures. CCC requires me to pay 181 USD to Elsevier / CCC Try it yourself It's irrelevant in practice who s the copyright owner , the total transparency is that Elsevier can extort rent for all CC -NC they pubish even if the author has copyright. Transparency = daylight robbery -- "I always retain copyright in my papers, and nothing in any contract I sign with any publisher will override that fact. You should do the same". Peter Murray-Rust Reader Emeritus in Molecular Informatics Unilever Centre, Dept. Of Chemistry University of Cambridge CB2 1EW, UK +44-1223-763069
_______________________________________________ GOAL mailing list [email protected] http://mailman.ecs.soton.ac.uk/mailman/listinfo/goal
